Related Experiment Video
Updated: May 12, 2026
07:08
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
Paul C Guest1, Daniel Martins-de-Souza2, Emanuel Schwarz1
1Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QT, UK.
Genome Medicine
|March 28, 2013
Summary
Proteomic profiling reveals molecular differences in schizophrenia, aiding in patient stratification and personalized treatment strategies. This approach enhances understanding of antipsychotic drug mechanisms and treatment outcomes.
Area of Science:
- Psychiatry and Molecular Biology
- Biochemistry and Pharmacology
Background:
- Schizophrenia is a complex psychiatric disorder with diverse clinical features, including mood/behavioral changes and co-occurring immune/metabolic abnormalities.
- Understanding the molecular underpinnings of schizophrenia's heterogeneity is crucial for developing effective treatments.
Purpose of the Study:
- To review the impact of proteomic profiling on schizophrenia diagnosis and therapeutics.
- To explore how proteomic methods can advance personalized medicine for schizophrenia patients.
Main Methods:
- Proteomic profiling techniques for characterizing molecular differences in schizophrenia.
- Analysis of proteomic data from preclinical models and patients treated with antipsychotics.
Main Results:
- Proteomic profiling has elucidated molecular differences, contributing to the understanding of schizophrenia's complexity and heterogeneity.
- Identification of molecular panels shows potential for predicting antipsychotic response and monitoring treatment efficacy.
Conclusions:
- Proteomic profiling offers a powerful tool for stratifying schizophrenia patients into distinct biochemical subtypes.
- This technology is pivotal for advancing personalized medicine, improving diagnosis, and optimizing therapeutic strategies in schizophrenia management.
Related Concept Videos
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...